TROY/TNFRSF19 Antibody (933202) [Alexa Fluor® 594]

• Reactivity: Hu
• Applications: Flow
• Clone: 933202
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Alexa Fluor 594

TROY/TNFRSF19 Antibody (933202) [Alexa Fluor® 594] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human TROY/TNFRSF19
  Glu30-Leu170
  Accession # Q9NS68
• Specificity: Detects human TROY/TNFRSF19 in direct ELISAs. Stains human TROY/TNFRSF19 transfectants but not irrelevant transfectants in flow cytometry.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity Statement: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • Flow Cytometry 0.25-1 ug/10^6 cells

Packaging, Storage & Formulations

• Storage: Store the unopened product at 2 - 8 °C. Do not use past expiration date.
• Buffer: Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

Notes

This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for TROY/TNFRSF19 Antibody (933202) [Alexa Fluor® 594]

• TAJ
• TAJ-alpha
• TAJToxicity and JNK inducer
• TNFRSF19
• TRADE
• TROY
• TROYtumor necrosis factor receptor superfamily member 19
• tumor necrosis factor receptor superfamily, member 19

Background

TROY (also known as TAJ and TNFRSF19) is a 45‑55 kDa member of the TNF receptor superfamily of molecules (1‑4). It is widely expressed in the embryo, but shows limited expression in adult. In particular, embryonic TROY is found in embryonic epithelium, neural tube, and mesenchyme, and developing neurons of the hippocampus and thalamus (5, 6). In the adult, TROY is found in the nervous system associated with dorsal root and retinal ganglia neurons, astrocytes, and microglia, and in hair follicles where it is expressed by dermal papilla matrix cells (4, 7, 8, 9). In human, TROY has also been found on melanoma cells, not normal melanocytes (10). TROY is reportedly a component of the Nogo-A receptor, taking the place of p75 in a membrane-bound LINGO-1:NgR1:TROY complex (6, 8, 9). This complex purportedly mediates axon repulsion initiated by one of five myelin-associated inhibitory factors (OMpg; CD100; Ephrin B3; Nogo-A; MAG) (6, 11). In the hair follicle, TROY binds LTa and acts with Eda to drive secondary hair follicle development (4, 12). Mature human TROY is a 394 amino acid (aa) type I transmembrane protein (1‑3). It possesses a 141 aa extracellular region (aa 30‑170) that contains three 40 aa TNFR cysteine motifs, and an extended 232 aa cytoplasmic domain (aa 192‑423). There is one potential isoform that shows a two aa substitution for aa 416‑423. The extracellular domains of human and mouse TROY share 90% aa identity.

1. Hu, S. et al. (1999) Genomics 62:103.
2. Eby, M.T. et al. (2000) J. Biol. Chem. 275:15336.
3. Kojima, T. et al. (2000) J. Biol. Chem. 275:20742.
4. Hashimoto, T. et al. (2008) Cell Cycle 7:106.
5. Pispa, J. et al. (2003) Gene Exp. Patterns 3:675.
6. Mi, S. (2008) Cytokine Growth Factor Rev. 19:245.
7. Satoh, J. et al. (2007) Neuropathol. Appl. Neurobiol. 33:99.
8. Shao, Z. et al. (2005) Neuron 45:353.
9. Park, J.B. et al. (2000) Neuron 45:345.
10. Spanjaard, R.A. et al. (2007) Int. J. Cancer 120:1304.
11. Venkatesh, K. et al. (2007) J. Cell Biol. 177:393.
12. Pispa, J. et al. (2008) Hum. Mol. Genet. 17:3380.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Uniprot:
  • Q9NS68()